Common infections remain a frequent explanation for swollen glands. A clinician weighs the duration, node examination, exposure history and systemic symptoms. A brief infection-associated illness that is improving is a different presentation from persistent or enlarging nodes. Absence of fever does not exclude KFD. No symptom checklist here can rule it out.

Takeaway: Ask “Should KFD be considered alongside infection, lupus and lymphoma?” rather than treating a matching symptom as confirmation.

Sources: [1][4][5]

A complete blood count with differential identifies which blood cells are low. CRP or ESR measures inflammation, not its cause. Ultrasound or other imaging can characterize nodes and guide sampling, but does not confirm KFD. Infection tests should follow specific exposures and examination findings. ANA and additional autoimmune tests answer a different question and need clinical context. Ask whether a lymph-node biopsy is needed and whether the sample is sufficient to assess tissue architecture and alternative diagnoses.

Takeaway: Bring exact test values and the pathology report. A negative infection test or an abnormal blood count alone is not a KFD diagnosis.

Sources: [1][4][6]

Characteristic findings include necrosis, fragmented nuclear material and histiocytes, with a paucity or absence of neutrophils. The pathologist also considers lupus-related lymphadenitis, lymphoma and infection. Excisional biopsy provides tissue architecture; the choice of sampling procedure depends on the node and clinical circumstances.

Takeaway: A report saying “reactive lymph node” is not automatically equivalent to a confirmed KFD diagnosis. Ask for the exact diagnostic wording.

Sources: [4]

For an uncomplicated, confirmed episode, discuss hydration, rest and appropriate fever or pain relief. Persistent symptoms require review of the diagnosis and course before escalating treatment. Corticosteroids and hydroxychloroquine appear in clinical reports and specialist care for selected severe or recurrent cases. Organ complications require condition-specific specialist management. Published prescribing frequencies are not evidence that one drug is superior.

Takeaway: Agree on the treatment goal, signs of response, adverse-effect monitoring and review date. Prescription choices and tapering require the treating clinician.

Sources: [1][4]

Use the study data above as context. Recorded recurrence in an all-age cohort cannot be substituted for a child-specific time-to-event estimate. Distinguish symptoms that never cleared, symptoms returning around treatment changes, and a new episode after a symptom-free interval. When a new episode occurs, its cause needs reassessment rather than assuming every fever is KFD.

Takeaway: Record the recovery date as carefully as the onset date; without it, the course is difficult to classify.

Sources: [1][2][3]

The American College of Rheumatology notes that up to 15% of healthy people can have a positive ANA. The significance depends on symptoms, examination, test pattern and titer, medications and other results. New rash, joint symptoms, mouth ulcers or light sensitivity deserve context-specific review. A pre-existing autoimmune condition, one diagnosed at the same time as KFD, and a later diagnosis are different situations.

Takeaway: Bring the original report and dates. Do not start treatment merely because ANA is positive, or assume that a historical positive result explains all new symptoms.

Sources: [6]

NHS guidance advises assessment when swollen glands enlarge or have not gone down within one week, or occur with night sweats, a very high temperature or no other infection symptoms. Difficulty breathing or very difficult swallowing needs urgent help. Severe breathing difficulty, confusion or loss of consciousness calls for local emergency services.

Takeaway: These are general lymph-node warning signs, not a KFD severity score. Use them regardless of whether KFD has been diagnosed.

Sources: [5]

Keep a short record of measured temperature, node changes, weight, fatigue and the dates of medication changes. Note missed school or work and difficulty eating or drinking. Bring a medication list and previous blood and tissue reports. Agree with the team on return to normal activity, whom to contact if symptoms recur, and whether any tests need repeating.

Takeaway: Ask for a specific review plan. The cohort studies do not establish one universal repeat-test schedule for every patient.

Sources: [2][5]

The calculator below reproduces the published Xie equation. Its validation used a random subset of the same retrospective multicenter dataset, not an independent external population. AUC describes ranking, not the percentage of individual predictions that are correct. The equation does not select a drug, establish a diagnosis or determine an emergency response.

Takeaway: Use the score to understand the published research and discuss applicability. Do not order extra tests solely to fill this calculator.

Sources: [3]